Treat to target? Efficacy of insulin use in patients with Type 2 diabetes (T2DM) in a secondary care setting

被引：0

作者：

Muraleedharan, V. ^{[1
]}

Caddick, L. ^{[1
]}

Hardisty, C. ^{[1
]}

Tesfaye, S. ^{[1
]}

Scott, A. ^{[1
]}

机构：

[1] Royal Hallamshire Hosp, Dept Diabet, Sheffield S10 2JF, S Yorkshire, England

来源：

DIABETIC MEDICINE | 2007年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：75 / 75

页数：1

共 50 条

[21] Factors Associated with Insulin Intensification Strategies in Uncontrolled Type 2 Diabetes (T2DM)
Korytkowski, Mary T.
Lombardero, Manuel
Brooks, Maria M.
Orchard, Trevor J.
Kanter, Justin
Siminerio, Linda M.
DIABETES, 2014, 63 : A307 - A307
[22] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Concomitant Heart Failure
Kosiborod, Mikhail
Gause-Nilsson, Ingrid Ami
Sonesson, Christian
Sugg, Jennifer E.
Johnsson, Eva
DIABETES, 2015, 64 : A313 - A313
[23] Physiologic Dose Response Effects of Insulin Glargine in Type 2 Diabetes (T2DM
Wang, Zhihui
Briscoe, Vanessa J.
Hedrington, Maka S.
Gogitidze, Nino
Richardson, Antoinette
Ertl, Andrew C.
Davis, Stephen N.
DIABETES, 2009, 58 : A150 - A150
[24] TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) WITH SITAGLIPTIN-EFFICACY AND SAFETY IN A REAL-LIFE SETTING
Kusterer, K.
Ruessmann, H. J.
Hens, C.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 52 - 52
[25] Real-World Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
Chow, Wing
Buysman, Erin K.
Rupnow, Marcia F. T.
Henk, Henry J.
DIABETES, 2015, 64 : A347 - A348
[26] Treat to target efficacy of troglitazone added to insulin in type 2 diabetes patients in endocrine and primary care practice settings
Hirsch, IB
Sasiela, B
Thompson, RG
Maggs, DG
DIABETES, 2000, 49 : A90 - A90
[27] Insulin initiation and intensification in patients with T2DM for the primary care physician
Unger, Jeff
DIABETES METABOLIC SYNDROME AND OBESITY, 2011, 4 : 253 - 261
[28] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
Pan, Xiaoyu
Liu, Qing
Song, Kexiu
Chai, Shangyu
Li, Fei
Huang, Yueye
Bhavna, Bhavna
Jhummon, Navina Priya
Qu, Shen
DIABETES, 2013, 62 : A492 - A492
[29] Consideration of Comorbidities in Treatment Choice for Patients with Type 2 Diabetes (T2DM)
Ritchey, Mary E.
Engel, Samuel S.
Liu, Zhiwen
Ntabadde, Catherine
Senderak, Michael
Shankar, Ravi
Qiu, Ying
Radican, Larry
Rajpathak, Swapnil
Brodovicz, Kimberly G.
DIABETES, 2014, 63 : A636 - A636
[30] Hyperglycemia Drives Glycemic Variability in Patients with Type 2 Diabetes (T2DM)
Olawsky, Evan A.
Zhang, Yuan
Alvear, Alison C.
Eberly, Lynn E.
Chow, Lisa S.
DIABETES, 2020, 69

← 1 2 3 4 5 →